Price
Financials
Standalone, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 0.05 | 0.05 | 0.06 | 0.06 | 0.06 | 0.06 | 0.07 | 0.07 | 0.07 | 0.07 | 0.06 | 0.08 |
| Operating costs | 0.05 | 0.04 | 0.05 | 0.11 | 0.05 | 0.04 | 0.05 | 0.08 | 0.04 | 0.05 | 0.06 | 0.08 |
| EBITDA | 0.00 | 0.01 | 0.01 | -0.05 | 0.01 | 0.02 | 0.02 | -0.01 | 0.03 | 0.02 | 0.00 | 0.00 |
| EBITDA margin % | 0.00% | 20.00% | 16.67% | -83.33% | 16.67% | 33.33% | 28.57% | -14.29% | 42.86% | 28.57% | 0.00% | 0.00% |
| Depreciation & amortisation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Finance costs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non-operating income | 0.02 | 0.00 | 0.09 | 0.07 | 0.02 | 0.01 | 0.08 | 0.03 | 0.03 | 0.03 | 0.02 | 0.01 |
| Pre-tax profit | 0.02 | 0.01 | 0.10 | 0.02 | 0.03 | 0.03 | 0.10 | 0.02 | 0.06 | 0.05 | 0.02 | 0.01 |
| Effective tax rate % | 0.00% | 0.00% | 20.00% | 0.00% | 33.33% | 33.33% | 10.00% | 0.00% | 33.33% | 20.00% | 50.00% | 0.00% |
| Profit after tax | 0.01 | 0.00 | 0.08 | 0.01 | 0.02 | 0.02 | 0.09 | 0.01 | 0.05 | 0.04 | 0.02 | 0.01 |
| Earnings per share (Rs) | 0.01 | 0.00 | 0.08 | 0.01 | 0.02 | 0.02 | 0.09 | 0.01 | 0.05 | 0.04 | 0.02 | 0.01 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 0.34 | 0.45 | 0.15 | 0.10 | 0.04 | 0.15 | 0.15 | 0.15 | 0.21 | 0.25 | 0.28 | 0.28 |
| Operating costs | 0.21 | 0.24 | 0.53 | 0.30 | 0.20 | 0.20 | 0.26 | 0.99 | 0.26 | 0.26 | 0.23 | 0.23 |
| EBITDA | 0.13 | 0.21 | -0.38 | -0.20 | -0.16 | -0.05 | -0.11 | -0.84 | -0.05 | -0.01 | 0.05 | 0.05 |
| EBITDA margin % | 38.24% | 46.67% | -253.33% | -200.00% | -400.00% | -33.33% | -73.33% | -560.00% | -23.81% | -4.00% | 17.86% | 17.86% |
| Depreciation & amortisation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Finance costs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non-operating income | -0.13 | -0.21 | 0.38 | 0.20 | 0.17 | 0.17 | 0.17 | 1.00 | 0.18 | 0.18 | 0.10 | 0.09 |
| Pre-tax profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.11 | 0.05 | 0.14 | 0.13 | 0.17 | 0.15 | 0.14 |
| Effective tax rate % | 0.00% | 27.27% | 20.00% | 21.43% | 15.38% | 17.65% | 26.67% | |||||
| Profit after tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.08 | 0.04 | 0.11 | 0.11 | 0.14 | 0.11 | 0.12 |
| Earnings per share (Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.08 | 0.04 | 0.11 | 0.11 | 0.14 | 0.11 | 0.12 |
| Paid out as dividend % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Revenue CAGR | -2% | 13% | 23% | 8% | ||
| Profit CAGR | -2% | 7% | 29% | -14% | ||
| Share price CAGR | 15% | % | 0% | -32% | ||
| Average return on equity | 0% | -1% | 1% | 1% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net block (property, plant) | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital work in progress | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 7.75 | 7.56 | 5.63 | 4.79 | 4.07 | 4.07 | 4.39 | 4.39 | 2.47 | 2.35 | 2.23 | 2.28 |
| Current & other assets | 1.99 | 2.22 | 4.11 | 4.75 | 5.39 | 5.41 | 5.21 | 5.41 | 7.77 | 7.68 | 7.99 | 8.10 |
| Total assets | 9.87 | 9.90 | 9.86 | 9.66 | 9.58 | 9.60 | 9.72 | 9.80 | 10.24 | 10.03 | 10.22 | 10.38 |
| Share capital | 10.06 | 10.06 | 10.06 | 10.06 | 10.06 | 10.06 | 10.06 | 10.06 | 10.06 | 10.06 | 10.06 | 10.06 |
| Reserves & surplus | -0.31 | -0.31 | -0.46 | -0.45 | -0.50 | -0.49 | -0.55 | -0.51 | -0.22 | -0.11 | 0.03 | 0.18 |
| Total debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.15 | 0.17 | 0.28 | 0.00 | 0.00 | 0.00 |
| Other liabilities & provisions | 0.12 | 0.15 | 0.26 | 0.05 | 0.02 | 0.03 | 0.06 | 0.08 | 0.12 | 0.08 | 0.13 | 0.14 |
| Equity + liabilities | 9.87 | 9.90 | 9.86 | 9.66 | 9.58 | 9.60 | 9.72 | 9.80 | 10.24 | 10.03 | 10.22 | 10.38 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -1.17 | -0.15 | -1.78 | -0.47 | -0.66 | -0.02 | 0.40 | -0.09 | -2.46 | 0.10 | -0.21 | 0.00 |
| Investing cash flow | 1.11 | 0.19 | 1.72 | 0.54 | 0.55 | 0.00 | -0.50 | 0.12 | 2.28 | 0.18 | 0.19 | 0.00 |
| Free cash flow (after capex) | -1.25 | -0.15 | -1.78 | -0.47 | -0.66 | -0.02 | 0.40 | 0.03 | -2.46 | 0.10 | -0.21 | 0.00 |
| Financing cash flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.15 | 0.02 | 0.12 | -0.28 | 0.00 | 0.00 |
| Net change in cash | -0.06 | 0.04 | -0.06 | 0.06 | -0.11 | -0.02 | 0.05 | 0.05 | -0.07 | 0.00 | -0.02 | 0.00 |
| Cash conversion (OCF / EBITDA) % | -1,170% | -115% | -848% | 124% | 320% | 0% | -820% | 55% | 289% | -240% | 1,400% | 80% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on capital employed % | 1.03% | 1.33% | 2.17% | 0.00% | 0.00% | 0.10% | 1.25% | 0.62% | -6.55% | 0.70% | 1.00% | 1.48% |
| Receivable days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5,961.67 | 4,710.24 | 4,380.00 | 4,067.14 |
| Inventory days | ||||||||||||
| Payable days | ||||||||||||
| Cash cycle (days) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5,961.67 | 4,710.24 | 4,380.00 | 4,067.14 |
| Working capital days | -237.25 | -161.03 | -202.78 | -121.67 | 0.00 | 730.00 | 146.00 | -24.33 | 5,718.33 | 4,571.19 | 4,204.80 | 3,897.68 |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Retail & others % | 100.00% | 100.00% | 99.99% | 100.01% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 99.99% | 99.99% | 99.99% |
| Shareholder count | 2,055 | 2,074 | 2,087 | 2,104 | 2,143 | 2,172 | 2,193 | 2,205 | 2,219 | 2,222 | 2,226 | 2,242 |
Fundamentals
Market value₹ 3.77 Cr.
Last price₹ 3.75
P/E (trailing)31.4
Book value / share₹ 10.2
Return on capital1.48 %
Return on equity1.08 %
Dividend yield0.00 %
Face value₹ 10.0
Revenue CAGR (TTM)8%
Profit CAGR (TTM)-14%
Standalone figures.
Valuation
Market capRs 4 Cr
Enterprise valueRs 4 Cr
P/E (TTM)29.94x
Price to book0.35x
Price to sales12.83x
EV / EBITDA25.59x
EV / EBIT25.59x
EV / sales12.80x
Earnings yield3.34%
P/E, 3-year average34.54x
P/B, 3-year average0.40x
P/E, 5-year average36.10x
P/B, 5-year average0.36x
Profitability
Operating margin (excl. other income)17.86%
Operating margin (incl. other income)53.57%
EBITDA margin50.00%
Pre-tax margin50.00%
Net profit margin42.86%
Net margin, latest quarter12.50%
ROE1.08%
ROCE1.48%
ROA1.07%
ROE, 3-year average1.20%
ROCE, 3-year average1.49%
ROA, 3-year average1.18%
ROE, 5-year average1.03%
ROCE, 5-year average1.34%
ROA, 5-year average1.01%
ROIC (approx.)1.00%
Tax rate26.67%
Other income / net worth0.98%
Growth
Sales growth (latest year)12.00%
Profit growth (latest year)-21.43%
Sales CAGR, 3 years23.13%
Sales CAGR, 5 years13.30%
Profit CAGR, 3 years0.00%
Profit CAGR, 5 years6.58%
Sales growth QoQ33.33%
Profit growth QoQ-50.00%
Sales growth YoY (latest quarter)14.29%
Profit growth YoY (latest quarter)0.00%
Per share
EPS (TTM)Rs 0.12
EPS (latest year)Rs 0.11
EPS (latest quarter)Rs 0.01
EPS, 3-year averageRs 0.12
EPS, 5-year averageRs 0.10
Book value per shareRs 10.17
Sales per shareRs 0.28
Efficiency
Asset turnover0.03x
Debtor days4067 days
Debtors turnover0.09x
Leverage
Cash and bankRs 0 Cr
Net debtRs -0 Cr
Net debt / EBITDA-0.07x
Owners' fund to total sources98.65%
Statement figures
Net sales (TTM)Rs 0 Cr
Net sales (latest year)Rs 0 Cr
Sales (latest quarter)Rs 0 Cr
Operating profit excl. other income (latest year)Rs 0 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs 0 Cr
PBDT (TTM)Rs 0 Cr
Profit before tax (TTM)Rs 0 Cr
Tax (latest year)Rs 0 Cr
Net profit (TTM)Rs 0 Cr
Net profit (latest year)Rs 0 Cr
Net profit (latest quarter)Rs 0 Cr
Cost of goods sold (latest year)Rs 0 Cr
Total expenditure (latest year)Rs 0 Cr
Total income (latest year)Rs 0 Cr
Share capitalRs 10 Cr
ReservesRs 0 Cr
Shareholders' fundsRs 10 Cr
Total assetsRs 10 Cr
InvestmentsRs 2 Cr
ReceivablesRs 3 Cr
Other liabilitiesRs 0 Cr
Shares outstanding (crore)1.01
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 29.9 is at the 28th percentile of its own 3.9-year range
(median 38.2, low 15.4, high 164.1).
P/B 0.35 is at the 23th percentile (median 0.45).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | 531219 | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | +0.6% | -2.8% | +3.3 pts |
| 1 month | +2.9% | -6.8% | +9.7 pts |
| 3 months | +13.3% | -7.6% | +21.0 pts |
| 3 years | -6.1% | +14.2% | -20.2 pts |
| 5 years | +119.0% | +27.9% | +91.1 pts |
Red flags
F-score 5 of 6| look | Profit leans on other income Other income was 67% of pre-tax profit in 2026 |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹0 Cr +14.3% vs Jun 2025.
Net profit ₹0 Cr +0.0%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 447,476 | 35.4 | 20.5 % |
| Divis Laboratories Ltd | 250,363 | 84.0 | 22.0 % |
| Torrent Pharmaceuticals Ltd | 186,152 | 83.4 | 15.2 % |
| Zydus Lifesciences Ltd | 119,750 | 24.6 | 21.1 % |
| Cipla Ltd | 111,430 | 31.1 | 15.5 % |
| Laurus Labs Ltd | 106,928 | 97.8 | 17.8 % |
| Mankind Pharma Ltd | 105,120 | 49.3 | 13.5 % |
| Dr Reddys Laboratories Ltd | 104,494 | 32.4 | 13.0 % |
| Aurobindo Pharma Ltd | 97,682 | 25.8 | 12.9 % |
| Lupin Ltd | 93,840 | 15.8 | 29.9 % |
| Glenmark Pharmaceuticals Ltd | 68,905 | 22.1 | 39.8 % |
| Alkem Laboratories Ltd | 62,772 | 27.6 | 21.2 % |
| Biocon Ltd | 61,439 | 84.5 | 3.61 % |
| Abbott India Ltd | 57,949 | 35.9 | 44.8 % |
| Gland Pharma Ltd | 49,333 | 43.1 | 15.1 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Shyama Computronics and Services Ltd?
Shyama Computronics and Services Ltd (531219) has a market capitalisation of Rs 3.77 Cr. at the 2026-10-01 close.
What is the P/E ratio of Shyama Computronics and Services Ltd?
Shyama Computronics and Services Ltd trades at a P/E of 31.4 on trailing twelve-month profit, at the 2026-10-01 close.
What were Shyama Computronics and Services Ltd's latest quarterly results?
In the Jun 2026 quarter, Shyama Computronics and Services Ltd sales was Rs 0 Cr (+14.3% vs Jun 2025) and net profit was Rs 0 Cr.